Quebec Proposes Expanding The Role Of Pharmacists 1st Part: Broadening The Scope Of Professional Acts That Pharmacists Are Permitted To Perform

NR
Norton Rose Fulbright Canada LLP

Contributor

Norton Rose Fulbright Canada LLP logo
Norton Rose Fulbright is a global law firm providing the world’s preeminent corporations and financial institutions with a full business law service. The firm has more than 4,000 lawyers and other legal staff based in Europe, the United States, Canada, Latin America, Asia, Australia, Africa and the Middle East.
In this legal update and in a forthcoming legal update, we will be addressing two proposed regulations published by the Office des professions du Québec.
Canada Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

In this legal update and in a forthcoming legal update, we will be addressing two proposed regulations published by the Office des professions du Québec. These proposed regulations are part of several legislative initiatives aimed at granting pharmacists greater professional autonomy and at broadening the scope of the professional acts they are permitted to perform.  

In particular, the Regulation respecting certain professional activities that may be engaged in by a pharmacist proposes to broaden the conditions under which pharmacists will be able to prescribe, adjust or stop certain medications.

The Règlement sur l'amorce et la modification d'une thérapie médicamenteuse, sur l'administration d'un médicament et sur la prescription de tests par un pharmacien (Regulation respecting the initiation and amendment of a drug therapy, the administration of a drug and the prescribing of tests by a pharmacist) includes the following amendments to the current regulations: 

  • Authorizing pharmacists to assess, adjust and stop a patient's drug therapy.
  • Authorizing pharmacists to substitute one drug for another when the latter poses a risk to patient safety, the patient's clinical situation justifies the swift initiation of therapy and the prescriber cannot be reached in a timely fashion. 
  • Introducing consultation requests, whereby professionals with prescribing authority may seek consultations from pharmacists, following which pharmacists can prescribe certain drugs and assess, initiate or modify a patient's drug therapy.
  • Introducing advanced practice agreements in partnership between pharmacists and specialized physicians or nurse practitioners.
  • Authorizing pharmacists to administer certain vaccines. 

Originally published 16 July, 2020


About Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global law firm. We provide the world's preeminent corporations and financial institutions with a full business law service. We have 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

For more information about Norton Rose Fulbright, see nortonrosefulbright.com/legal-notices.

Law around the world
nortonrosefulbright.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More